Physician

Amir Manzoor, MD

According to 2025 Medicare claims, Amir Manzoor, MD (NPI: 1801804117) practices endocrinology in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is AMIR MANZOOR, MD, PA (NPI: 1558558171; TIN: 593768197) and primary practice location at 32405-4463.

Manzoor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,308 traditional Medicare patients, billed 7,307 HCPCS/CPT codes, and received $509,899 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 6,279 prescription claims across 797 beneficiaries totaling $2,755,204 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 1,815 claims. Open Payments data shows 37 records totaling $1,094. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,879,893 and ending at $2,755,204. For DME billing, reported payments moved sharply higher in recent years, from $147,409 to $568,185.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,393	9,047	$558,414
2016	1,455	9,645	$565,897
2017	1,439	8,739	$484,563
2018	1,429	9,592	$528,071
2019	1,423	10,953	$568,987
2020	1,505	8,934	$573,322
2021	1,383	7,596	$531,876
2022	1,243	6,834	$439,697
2023	1,326	8,400	$542,505
2024	1,308	7,307	$509,899

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	629	9,662	$1,879,893
2016	712	9,659	$2,234,420
2017	735	9,749	$3,049,343
2018	827	9,833	$3,669,500
2019	886	9,478	$3,906,335
2020	821	6,850	$2,995,427
2021	779	6,319	$3,047,793
2022	730	6,833	$3,312,048
2023	793	7,836	$4,138,487
2024	797	6,279	$2,755,204

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	750	2,233	$184,028
2016	724	1,908	$132,903
2017	624	1,486	$184,104
2018	665	1,852	$262,520
2019	632	1,747	$301,082
2020	590	2,186	$436,237
2021	533	2,208	$406,521
2022	509	2,538	$506,930
2023	527	2,907	$614,378
2024	505	1,815	$596,558

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	180	180	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	772	2,230	$87
76536	Ultrasound scan of head and neck soft tissue	375	384	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	483	977	$64
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	191	1,398	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	569	18,344	$671,247
Ozempic	Semaglutide	323	12,138	$392,960
Tresiba Flextouch U-200	Insulin Degludec	109	6,714	$198,664
Jardiance	Empagliflozin	128	8,370	$159,215
Farxiga	Dapagliflozin Propanediol	138	8,330	$153,296

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	228	988	$428,542
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	57	155	$47,836
E0784	External ambulatory infusion pump, insulin	Y	19	110	$37,197
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	22	54	$31,877
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	11	50	$19,020

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$1,094	Senseonics, Incorporated
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amir Manzoor, MD?

Tedicare shows public-source Medicare data for Amir Manzoor, MD (NPI 1801804117), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amir Manzoor, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amir Manzoor, MD?

Amir Manzoor, MD is linked to AMIR MANZOOR, MD, PA (billing NPI 1558558171) in the available physician profile data.

Does Amir Manzoor, MD have Open Payments data?

Amir Manzoor, MD has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.